Sunday, June 20, 2021
ADVT 
International

Britain to test mixing and matching of COVID-19 vaccines

Darpan News Desk The Canadian Press, 04 Feb, 2021 01:12 AM
  • Britain to test mixing and matching of COVID-19 vaccines

British scientists are starting a study Thursday to find out if it's OK to mix and match COVID-19 vaccines.

The vaccines being rolled out now require two doses, and people are supposed to get two shots of the same kind, weeks apart.

Guidelines in Britain and the U.S. say the vaccines aren't interchangeable, but can be mixed if the same kind isn’t available for the second dose or if it’s not known what was given for the first shot.

Participants in the government-funded study will get one shot of the AstraZeneca vaccine followed by a dose from Pfizer, or vice versa.

“This study will give us greater insight into how we can use vaccines to stay on top of this nasty disease,” said Jonathan Van Tam, the U.K.'s deputy chief medical officer.

He said that given the challenges of immunizing millions of people amid a global vaccine shortage, there would be advantages to having data that could support more “flexible” immunization campaigns.

COVID-19 vaccines all train the body to recognize the coronavirus, mostly the spike protein that coats it. The ones from AstraZeneca and Pfizer use different technologies. AstraZeneca's uses a common cold virus to carry the spike gene into the body. Pfizer's is made by putting a piece of genetic code called mRNA — the instructions for that spike protein — inside a little ball of fat.

The British research is scheduled to run 13 months and will also test different intervals between doses, four weeks and 12 weeks apart.

A study published this week on the Russian-made Sputnik V vaccine showed it was about 91% effective in preventing COVID-19. Some immunologists credit the fact that the vaccine uses two slightly different shots, made with similar technology to AstraZeneca's.

But the AstraZeneca and Pfizer vaccines are "so different that it’s really hard to know if that would work,” said Alexander Edwards, an associate professor in biomedical technology at Britain's University of Reading.

Matthew Snape, the new study's leader at Oxford University, which helped develop the AstraZeneca vaccine, called for British volunteers over age 50 to sign up; scientists are hoping to enrol more than 800 people.

If the vaccines can be used interchangeably, "this will greatly increase the flexibility of vaccine delivery," he said in a statement. "(It) could provide clues as to how to increase the breadth of protection against new virus strains.”

In recent weeks, Britain, the European Union and numerous other countries have been hit with vaccine supply issues: AstraZeneca said it would dramatically reduce the expected number of doses it could deliver due to manufacturing delays and Pfizer also slowed deliveries while it upgraded its Belgian factory.

MORE International ARTICLES

Trump supporters mass in D.C. as Biden era begins

Trump supporters mass in D.C. as Biden era begins

Several Republican lawmakers will formally object to president-elect Joe Biden's win, citing phoney allegations of election fraud — a futile exercise that will likely do little beyond delaying the inevitable.

Trump supporters mass in D.C. as Biden era begins

Fauci: US could soon give 1 million vaccinations a day

Fauci: US could soon give 1 million vaccinations a day

Vaccinations have already begun speeding up, reaching roughly half a million injections a day, he pointed out.

Fauci: US could soon give 1 million vaccinations a day

Trump call ratchets up political tension in U.S.

Trump call ratchets up political tension in U.S.

That demand is sure to reverberate Tuesday, when two run-off elections in Georgia will decide whether Democrats or Republicans control the Senate.

Trump call ratchets up political tension in U.S.

'Relieved': US health workers start getting COVID-19 vaccine

'Relieved': US health workers start getting COVID-19 vaccine

Shipments of precious frozen vials of vaccine made by Pfizer Inc. and its German partner BioNTech began arriving at hospitals around the country Monday.

'Relieved': US health workers start getting COVID-19 vaccine

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

The go-ahead for the vaccine developed by American drugmaker Pfizer and Germany's BioNTech comes as the virus surges again in the United States and Europe, putting pressure on hospitals and morgues in some places and forcing new rounds of restrictions that have devastated economies.

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

Announcing the results on Monday, Moderna said it has submitted emergency use authorisation from the US Food and Drug Administration (FDA), to apply for a conditional marketing authorisation with the European Medicines Agency (EMA) and to progress with the rolling reviews, which have already been initiated with international regulatory agencies.

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent